TipRanks
Go Ultimate55% OFF

Sigyn Therapeutics (SIGY) Income Statement

Sigyn Therapeutics Income Statement

Last quarter (Q1 2026), Sigyn Therapeutics's total revenue was $0.00. In Q1, Sigyn Therapeutics's net income was $-922.56K. See Sigyn Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -1.36K$ -5.61K$ -8.86K$ -10.45K―
$ 1.78M$ 2.52M$ 2.46M$ 2.15M$ 2.01M
Depreciation and Amortization$ 1.36K$ 5.61K$ 8.86K$ 10.45K$ 19.15K
$ -1.78M$ -3.33M$ -2.45M$ -2.14M$ -2.53M
$ -1.79M$ -2.52M$ -2.46M$ -2.15M$ -2.01M
$ -1.58M$ -820.97K$ -1.69M$ -782.55K$ -996.40K
$ -3.36M$ -3.34M$ -4.15M$ -2.93M$ -3.00M
$ -3.36M$ -3.34M$ -4.15M$ -3.71M$ -3.40M
Per Share Metrics
Basic EPS$ -2.09$ -2.51$ -3.77$ -3.97$ -0.09
Diluted EPS$ -2.09$ -2.51$ -3.77$ -3.97$ -0.09
Weighted Average Shares Outstanding1.61M1.33M1.10M934.00K36.40M
Weighted Average Shares Outstanding (Diluted)1.61M1.33M1.10M934.00K36.40M

Currency in USD

Sigyn Therapeutics Earnings and Revenue History

-5M-2.5M02.5M-12000 %-8000 %-4000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin